Wełnicki, Marcin. “Why We Choose Fenofibrate? Fenofibrate in Long-Term Therapy – Larger Packages, Greater Benefits for Patients With Atherogenic Dyslipidemia”. Medycyna Faktow (J EBM) 18, no. 2(67) (June 30, 2025): 290-292. Accessed November 22, 2026. https://www.journalsmededu.pl/index.php/jebm/article/view/3385.